Current Opinion in Allergy and Clinical Immunology

Article	Citations
Clinical phenotypes of adult atopic dermatitis and related therapies	40
Vaccine allergy: evidence to consider for COVID-19 vaccines	32
Vernal keratoconjunctivitis and keratoconus	27
Omalizumab as monotherapy for food allergy	26
Update on omalizumab in allergen immunotherapy	26
Omalizumab as an adjuvant in food allergen immunotherapy	24
COVID-19 and X-linked agammaglobulinemia (XLA) – insights from a monogenic antibody deficiency	23
Small-airway dysfunction in paediatric asthma	23
Artificial stone silicosis	22
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity	21
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host–environmental interactions	20
Epithelial-to-mesenchymal transition in neutrophilic chronic rhinosinusitis	19
Autologous serum eye drops for ocular surface disorders	18
Cleaners and airway diseases	18
COVID-19 in complex common variable immunodeficiency patients affected by lung diseases	18
Choice of biologics in asthma endotypes	18
Antibody therapy for COVID-19	17
Cow's milk allergy	17
Role of clinical history in beta-lactam hypersensitivity	16
COVID-19 and autoimmune diseases: is there a connection?	15
Novel vaccines for allergen-specific immunotherapy	15
Application of exhaled nitric oxide (FeNO) in pediatric asthma	15
Inflammatory endotypes of CRSwNP and responses to COVID-19	14
Gastroesophageal reflux and asthma: when, how, and why	14
Air pollution and childhood asthma	13

Allergen immunotherapy and biologics in respiratory allergy: friends or foes?	12
The impact of obesity on immune function in pediatric asthma	12
Fractional exhaled nitric oxide and asthma treatment adherence	12
Epidemiology of anaphylaxis	12
Pediatric asthma in developing countries: challenges and future directions	12
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019	12
Probiotics in food allergy	11
Alpha1-antitrypsin deficiency and asthma	11
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	10
Predicting the course of asthma from childhood until early adulthood	10
Basophil activation test in food allergy: is it ready for real-time?	10
Biologics and severe asthma in children	9
Emerging approaches in the diagnosis and therapy in shellfish allergy	9
Grading the severity of anaphylaxis	9
Real-life studies in allergen immunotherapy	9
Impact of the exposome on food allergy development	9
Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy	9
Exploring the origin and regulatory role of mast cells in asthma	9
An update on the epigenetics of asthma	9
Drug allergy management in the elderly	8
How E-cigarettes and vaping can affect asthma in children and adolescents	8
Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review	8
Neutrophilic inflammation in chronic rhinosinusitis	8
Anaphylaxis across Europe: are pollen food syndrome and lipid transfer protein allergy so far apart?	8
Chronic rhinosinusitis: phenotypes and endotypes	8
Biologics for eosinophilic granulomatosis with polyangiitis	8
Clinical and biological markers in disease and biologics to treat chronic rhinosinusitis	8
Exhaled nitric oxide in asthma: from diagnosis to management	8
Occupational inhalant allergy in food handling occupations	8
Role of tissue-resident memory T cells in the pathophysiology of allergic contact dermatitis	8
Update on irritant-induced occupational asthma	8
Nanoparticles in allergen immunotherapy	7
Atopic dermatitis endotypes: knowledge for personalized medicine	7
Classifying cephalosporins: from generation to cross-reactivity	7
A review of food allergy-related costs with consideration to clinical and demographic factors	7
Biologics as treatment options for anaphylaxis	7
Food-labeling issues for severe food-allergic consumers	7
Is asthma a risk factor for coronavirus disease-2019 worse outcomes? The answer is no, but …	7
Cellular interactions in aspirin-exacerbated respiratory disease	7
Biologicals for the prevention of anaphylaxis	7
Updates in diagnosis and management of paediatric mastocytosis	6
Anaphylaxis in elderly people	6
Wheat oral immunotherapy	6
Strengthening the case for intralymphatic immunotherapy	6
Pulmonary function testing for the diagnosis of asthma in preschool children	6
Evaluating the glucagon-like peptide-1 receptor in managing asthma	6
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	6
Occupational respiratory and skin diseases among workers exposed to metalworking fluids	6
Management of adverse reactions induced by chemotherapy drugs	6
Allergy prevention through breastfeeding	6

Safety of anti-inflammatory drugs in children with asthma	6
Anaphylaxis and digital medicine	6
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	6
Recent advances in the diagnosis and management of tree nut and seed allergy	6
Paediatric allergy practice in the era of coronavirus disease 2019	6
Current strategies for phenotyping and managing asthma in preschool children	6
Gene therapy for inborn error of immunity – current status and future perspectives	6
Epidemiology of anaphylaxis: is the trend still going up?	5
Environment and the development of severe asthma in inner city population	5
Severe asthma and personalized approach in the choice of biologic	5
Personalized management for unmet needs with food allergy	5
Prevention of food allergy: can we stop the rise of IgE mediated food allergies?	5
Applying the new guidelines to asthma management in children	5
Novel therapies and the potential for a personalized approach to atopic dermatitis	5
Novel occupational causes of hypersensitivity pneumonitis	5
Economic burden of drug-induced anaphylaxis: what can we do better?	5
Neurostimulation for dry eye disease	5
Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding	5
New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease	5
Neuropathic pain and itch: mechanisms in allergic conjunctivitis	5
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	5
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma	5
An immunologist's perspective on anti-COVID-19 vaccines	4
Biologics in eosinophilic esophagitis	4
Thymic stromal lymphopoietin and alarmins as possible therapeutical targets for asthma	4
Molecular diagnosis contribution for personalized medicine	4
Wood dust and asthma	4
Consequences of severe asthma exacerbations	4
Occupational causes of chronic obstructive pulmonary disease: an update	4
Type-2-low severe asthma endotypes for new treatments: the new asthma frontier	4
Characteristics of allergen profile, sensitization patterns and Allergic Rhinitis in SouthEast Asia	4
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	4
Recent advances in the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome	4
Role of pharmacogenomics in T-cell hypersensitivity drug reactions	4
Social determinants of health and asthma	4
Dietary strategies for the prevention of asthma in children	4
Advances in gene therapy for inborn errors of immunity	4
Epidemiology of non-IgE-mediated food allergies: what can we learn from that?	4
New arrivals in anaphylaxis to foods	4
Olfactory and taste dysfunctions in COVID-19	4
Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?	4
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	4
Update on the use of allergen challenge chambers in immunotherapy: clinical implications	4
Regulatory T-cells in asthma	4
Clinical outcomes of efficacy in food allergen immunotherapy trials	3
Evidence-based management of eczema: five things that should be done more and five things that should be dropped	3
Emerging developments in the forefront of peanut oral immunotherapy	3
Optimal use of intranasal corticosteroids and intranasal saline, is there a clear answer?	3
New causes of immunologic occupational asthma 2014–2020	3
Autoimmune and autoinflammatory manifestations in inborn errors of immunity	3
Ocular mucous membrane pemphigoid: novel treatment strategies	3
COPD and biologic treatment: state of the art	3
The challenges and facilitators of self-management in pediatric asthma	3
Innate and adaptive immunity in allergic airway disease	3
Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis	3
E-cigarettes and asthma in adolescents	3
Clinical outcomes of AIT in the elderly population	3
Biologicals in IgE-mediated food allergy	3
Comparison of structural components and functional mechanisms within the skin vs. the conjunctival surface	3
Trends and determinants of epinephrine prescriptions: a proxy of anaphylaxis epidemiology?	3
Corneal complications of rheumatoid arthritis	3
Secondary prevention of latex allergy	3
Atopic endotypes as a modulating factor for SARS-CoV-2 infection: mechanisms and implications	3
Exposure to nanoparticles and occupational allergy	3
Is immunotherapy safe for treatment of severe asthma	3
Updates on treatment options in aspirin exacerbated respiratory disease	3
Psychosocial impact of ocular surface allergic inflammatory disorders	3
Association between silicosis and autoimmune disease	3
Drug allergy in primary care: systematic review to support quality improvement initiative of management and optimization of healthcare pathways	3
Current insights: a systemic review of therapeutic options for peanut allergy	3
Drug allergy desensitization is not a unique recipe	3
Hypersensitivity to gadolinium-based contrast	3
Hereditary alpha-tryptasemia	3
New approaches in childhood asthma treatment	3
To mix or not to mix in allergy immunotherapy vaccines	3
Exanthematous reactions to drugs in children	2
Environmental exposures: evolving evidence for their roles in adult allergic disorders	2
An update on patient reported outcomes in type 2 inflammation airway disease	2
MicroCrystalline Tyrosine-adsorbed immunotherapy	2
Biologics in atopic dermatitis	2

Management of food allergy based on oral food challenge	2
Updates of cancer hallmarks in patients with inborn errors of immunity	2
Interaction of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis	2
Coronavirus disease 2019 and pediatric asthma: friend or foe?	2
The new indications for biologicals in type 2 diseases: perspectives	2
Safety of allergen immunotherapy in children	2
Fungal bioaerosols as an occupational hazard	2
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	2
The development of the DEFASE project	2
New insights in mite immunotherapy – sublingual tablets	2
Prevalence and clinical characteristics of vernal keratoconjunctivitis in sub-Saharan Africa	2
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	2
Occupational respiratory allergy to reactive dyes	2
Exposome mapping in chronic respiratory diseases: the added value of digital technology	2
Perioperative anaphylaxis: when the allergological work-up goes negative	2
Editorial: Food allergy: from defense to attack	2
Nasal nitric oxide flux from the paranasal sinuses	2
The complexity in DNA methylation analysis of allergic diseases	2
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	2
Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease	2
An overview of the current state of food desensitization	2
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	2
Relationship between eliciting doses and the severity of allergic reactions to food	2
Biological therapies, asthma and coronavirus disease 2019	2
Precision medicine for cow's milk immunotherapy in clinical practice	2
Immunobiologicals and ocular surface disease	2